Ann: Appendix 4E - 30 June 2014, page-3

I wondered myself about exactly that statement. A bit of digging came up with the following nuances in wording which may explain it.

This from the announcement in Aug 2013.
'This regulatory approval for SDI’s Bayswater manufacturing facility by the Brazilian Government will allow the Company to expedite the introduction of new products into this large dental market including the surrounding Latin region.’


This from today's report.
'The company expects that there will be continued improvements in this subsidiary once it has received its GMP approval by the Brazilian regulatory authorities to allow manufacturing in that market'.

Could it be that the 2013 approval was for the 'Bayswater manufacturing facility' only and now they are seeking approval to manufacture in Brazil? ('in that market').
Looking for further cost savings by production in Brazil?

Still disappointing that in constant currency terms overall sales only increased by 3.8%. However the dollar worked for them, apart from in Brazil. The silver price also lent a hand. On the up side; the Brazilian sales increased by over 20% and they seem to be heading in the right direction in all markets with sales, sales teams, structures and marketing. Paid down debt, lower interest expense as a result and retained earnings strong. Closed today on a PE of 12.77.

July 3rd update forecast earnings $5.7ml - $6.2ml. And today's result ann showed earnings of $6.467ml. 8.7% above the mid range forecast and 4.3% above the top of the forecast range.

For what it's worth; my opinion is that the company have got themselves going in the right direction. Still dependent on which way the Aus dollar and silver price goes. But they seem to be doing a reasonable job of the things they can control.